Cas 724743-88-8,5-[(3,4-dioxo-3,4-dihydro-1-naphthalenyl)amino]-2-naphthalenesulfonic acid

724743-88-8

Post Buying Request

Basic information

Product Name: 5-[(3,4-dioxo-3,4-dihydro-1-naphthalenyl)amino]-2-naphthalenesulfonic acid
Synonyms: 5-[(3,4-dioxo-3,4-dihydro-1-naphthalenyl)amino]-2-naphthalenesulfonic acid
CAS NO:724743-88-8
Molecular Formula: C20H13NO5S
Molecular Weight: 379.38592
EINECS: N/A
Product Categories: N/A
Mol File: 724743-88-8.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-[(3,4-dioxo-3,4-dihydro-1-naphthalenyl)amino]-2-naphthalenesulfonic acid(CAS DataBase Reference)
NIST Chemistry Reference: 5-[(3,4-dioxo-3,4-dihydro-1-naphthalenyl)amino]-2-naphthalenesulfonic acid(724743-88-8)
EPA Substance Registry System: 5-[(3,4-dioxo-3,4-dihydro-1-naphthalenyl)amino]-2-naphthalenesulfonic acid(724743-88-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 724743-88-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

724743-88-8 Suppliers

Recommended suppliersmore

724743-88-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 724743-88-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,4,7,4 and 3 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 724743-88:
(8*7)+(7*2)+(6*4)+(5*7)+(4*4)+(3*3)+(2*8)+(1*8)=178
178 % 10 = 8
So 724743-88-8 is a valid CAS Registry Number.

724743-88-8Upstream product

724743-88-8Downstream Products

724743-88-8Relevant articles and documents

Discovery of Small-Molecule Inhibitors of the HSP90-Calcineurin-NFAT Pathway against Glioblastoma

Liu, Zhenzhen,Li, Hongli,He, Lian,Xiang, Yu,Tian, Chengsen,Li, Can,Tan, Peng,Jing, Ji,Tian, Yanpin,Du, Lupei,Huang, Yun,Han, Leng,Li, Minyong,Zhou, Yubin

, p. 352 - 7,365 (2019/03/19)

Glioblastoma (GBM) is among the most common and malignant types of primary brain tumors in adults, with a dismal prognosis. Although alkylating agents such as temozolomide are widely applied as the first-line treatment for GBM, they often cause chemoresis

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 724743-88-8